Dose-response characteristics of uterine responses in rats exposed to estrogen agonists

被引:28
作者
Barton, HA [1 ]
Andersen, ME [1 ]
Allen, BC [1 ]
机构
[1] ICF Kaiser, KS Crump Grp, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1006/rtph.1998.1244
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Assays for uterine response have played major roles in developing an understanding of estrogen-mediated processes and for identifying compounds with hormonal activity. Data from assays measuring increases in uterine wet weight in rats were evaluated in terms of their dose-response characteristics. Analysis using a Hill equation found inconsistent estimates for the ED50 (concentration giving half-maximal response) and n (steepness of response) among the assays. This variability reflects disparate assay protocols and limitations of the dose-response data collected in the experiments. Although uterine wet weight is easily measured, it arises from several physiological processes (e.g., water retention, cell proliferation). This contributes to the assay variability with different protocols. The potential use of the Dill equation for dose-response analysis to estimate a benchmark dose was also considered using these data sets as surrogates for receptor-mediated toxicological effects. Strengths and weaknesses were identified, but overall the Dill equation should likely become a favored option for determining a benchmark dose, particularly when a data set demonstrates a maximal response. For screening purposes, empirical analysis using the Hill equation provides adequate information for classifying and prioritizing compounds. To develop an understanding of how incremental exposures to compounds with estrogen agonist activities would affect intact adult females, quantitative analyses are required that account for the pharmacokinetics of estradiol and subsequent interactions of the receptor complexes in regulating the responses. (C) 1998 Academic Press.
引用
收藏
页码:133 / 149
页数:17
相关论文
共 50 条
  • [1] Estrogen induces early and timed activation of cyclin-dependent kinases 4, 5, and 6 and increases cyclin messenger ribonucleic acid expression in rat uterus
    Altucci, L
    Addeo, R
    Cicatiello, L
    Germano, D
    Pacilio, C
    Battista, T
    Cancemi, M
    Petrizzi, VB
    Bresciani, F
    Weisz, A
    [J]. ENDOCRINOLOGY, 1997, 138 (03) : 978 - 984
  • [2] RELATIONSHIP BETWEEN NUCLEAR RECEPTOR ESTROGEN BINDING AND UTEROTROPHIC RESPONSES
    ANDERSON, JN
    CLARK, JH
    PECK, EJ
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1972, 48 (06) : 1460 - &
  • [3] ESTROGEN-INDUCED UTERINE RESPONSES AND GROWTH - RELATIONSHIP TO RECEPTOR ESTROGEN BINDING BY UTERINE NUCLEI
    ANDERSON, JN
    PECK, EJ
    CLARK, JH
    [J]. ENDOCRINOLOGY, 1975, 96 (01) : 160 - 167
  • [4] NUCLEAR RECEPTOR-ESTROGEN COMPLEX - RELATIONSHIP BETWEEN CONCENTRATION AND EARLY UTEROTROPHIC RESPONSES
    ANDERSON, JN
    PECK, EJ
    CLARK, JH
    [J]. ENDOCRINOLOGY, 1973, 92 (05) : 1488 - 1495
  • [5] [Anonymous], TOXICOL SCI
  • [6] BARLOW RB, 1980, QUANTITATIVE ASPECTS
  • [7] BENCHMARK DOSE WORKSHOP - CRITERIA FOR USE OF A BENCHMARK DOSE TO ESTIMATE A REFERENCE DOSE
    BARNES, DG
    DASTON, GP
    EVANS, JS
    JARABEK, AM
    KAVLOCK, RJ
    KIMMEL, CA
    PARK, C
    SPITZER, HL
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1995, 21 (02) : 296 - 306
  • [8] Endocrine active compounds: From biology to dose response assessment
    Barton, HA
    Andersen, ME
    [J]. CRITICAL REVIEWS IN TOXICOLOGY, 1998, 28 (04) : 363 - 423
  • [9] BRANHAM WS, 1993, P SOC EXP BIOL MED, V203, P297
  • [10] Clark James H., 1994, P1011